Key result
Triple-valve endocarditis with extensive embolic disease proves fatal in an inoperable 37-year-old man.
Why the study?
Triple valve endocarditis is a rare presentation often requiring multivalvular surgery.
Case Report (n=1)
No
Highlights a rare case of S. aureus triple valve endocarditis in an intravenous drug user, emphasizing the frequent need for multivalvular surgery.
TVE in IV drug users warrants individualized surgical planning; extends sparse case literature but leaves open need for prospective data.
Triple valve endocarditis (TVE) is a rare presentation of endocarditis often requiring multivalvular surgery. Here we report a case of S. aureus triple valve endocarditis in a patient with a history of intravenous drug use and provide a literature review of TVE identification, treatment, and prognosis.
No takes yet. Share an insight, caveat, or question.
Vattikonda et al. (2023) conducted a case report in Triple-valve endocarditis (n=1). Antibiotic therapy (vancomycin, cefepime, then nafcillin) was evaluated on Clinical outcome. A 37-year-old man with triple-valve endocarditis and extensive embolic disease was deemed a poor surgical candidate and died after withdrawal of care on day 3 of hospitalization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: